BRISTOL MYERS SQUIBB CO BMY Cash Flow

Bristol myers squibb co (BMY)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Dec'09	Sep'09	Jun'09	Mar'09
Cash Flows From Operating Activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
-766	-1,060	1,366	1,439	1,715	1,158	1,912	382	1,495	-2,329	856	922	1,526	898	1,215	1,188	1,206	-188	730	-110	1,199	27	732	334	936	735	692	530	623	924	-713	808	1,482	1,231	1,355	1,307	1,367	842	1,302	1,268	1,101	8,353	1,290	1,298	921
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Net earnings attributable to noncontrolling interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1	9	0	-6	14	-1	-2	163	381	379	386	405	381	359	353	341	358	328	324	315	283
Depreciation, Depletion and Amortization
2,477	1,236	171	169	170	172	165	157	143	197	188	211	193	122	105	90	65	76	105	91	104	103	112	115	137	181	180	189	213	199	195	148	139	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Income Tax Expense (Benefit)
-53	-337	-500	-165	78	206	-124	-197	160	170	262	91	-70	296	-183	-71	-246	-398	110	-52	-7	-485	-93	-74	110	-82	-74	-153	-182	-493	-817	-124	204	142	30	66	177	322	3	7	90	-16	67	85	27
Share-based Payment Arrangement, Noncash Expense
210	284	56	48	53	53	62	51	55	50	50	54	45	56	48	54	47	59	63	59	54	66	48	50	49	51	45	46	49	46	26	40	42	41	39	43	38	50	47	49	47	53	42	45	43
Impairment of Long-Lived Assets to be Disposed of
53	16	9	129	45	16	6	24	80	104	4	141	78	-12	7	49	19	168	4	7	13	15	28	311	47	34	2	1	3	62	1,830	190	98	0	13	0	15	21	7	0	200	-	-	-	-
Depreciation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	111	117	-	102	124	122	121	117	121	110
Amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	95	73	-	66	67	65	61	64	56	57
Pension settlements and amortization
11	5	1,557	60	66	41	41	54	50	88	41	55	52	47	39	44	39	67	68	60	50	765	54	72	80	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Divestiture gains and royalties
173	179	1,356	154	166	170	325	242	255	160	135	135	276	105	155	420	507	-75	240	91	234	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Asset acquisition charges
-	-	-	-	-	0	0	25	60	250	310	200	0	0	35	139	100	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity investment, (gain) loss
-339	294	-261	71	175	-268	97	-356	15	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability
556	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from Amylin diabetes alliance
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-41	-57	-	-8	-26	35	0	60	49	26
Other Noncash Income (Expense)
42	1	7	8	6	1	16	13	14	5	-14	-78	-33	-20	32	14	10	-32	150	-154	21	-541	365	-65	262	-2	0	8	3	56	-8	-3	-10	9	25	2	111	-2	19	5	10	480	-35	-122	44
Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]
Changes in operating assets and liabilities:
Increase (Decrease) in Receivables
743	-318	-127	-71	-236	207	334	107	-219	-108	85	208	246	-93	44	428	424	356	319	176	91	278	53	28	-107	-59	159	86	318	-5	-99	-652	108	68	-176	237	91	148	68	-255	309	-304	13	145	-81
Increase (Decrease) in Inventories
-1,448	-470	35	7	-35	64	30	118	4	36	-65	-13	71	45	-4	67	44	134	-69	-111	-51	92	5	13	144	37	-165	10	163	-32	-35	102	68	43	-96	162	84	-193	49	13	-25	-83	11	-28	18
Increase (Decrease) in Accounts Payable
703	181	-108	20	136	127	-85	140	-241	257	148	29	-114	246	-106	41	-77	299	-600	-535	-83	-107	175	-100	-12	111	98	256	-53	89	-99	-254	32	284	-103	350	62	238	23	-65	119	244	-38	60	206
Deferred income
-	-	-	-	-	0	-8	69	23	-551	-89	-76	74	-509	182	28	235	65	315	-496	334	209	-19	96	327	263	83	404	215	195	57	87	-44	-	-	-	-	-	-	-	-	-	-	-	-
Increase (Decrease) in Income Taxes Payable
229	860	112	-185	120	4	-17	102	114	2,754	-65	51	414	-270	259	-494	52	117	53	-57	81	89	273	24	-215	-2	159	-108	77	-132	7	97	-22	-114	97	-47	-70	-49	8	-89	-106	2	-5	-10	71
Increase (Decrease) in Other Operating Assets and Liabilities, Net
355	-17	-899	-703	917	-826	-129	-374	695	-226	-154	-170	777	-569	-30	-300	683	-832	-309	-300	824	-320	-27	-205	544	190	138	-443	875	328	-384	248	997	-272	-229	-15	574	-169	-322	182	557	2,016	211	-2,040	745
Net Cash Provided by (Used in) Operating Activities
3,894	2,038	2,556	2,083	1,390	2,429	1,279	1,057	1,175	1,117	1,713	1,584	861	1,443	1,404	439	-228	884	524	71	626	572	903	1,056	617	1,410	1,053	1,510	-428	836	4,584	1,134	387	1,568	1,698	1,093	481	1,595	1,383	1,049	464	1,344	1,473	796	452
Cash Flows From Investing Activities:
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale
1,394	1,345	176	1,077	1,211	926	373	638	442	2,102	2,013	1,120	1,163	1,135	880	1,034	1,760	345	641	300	1,508	1,324	1,833	562	376	295	242	727	551	506	1,047	1,147	2,190	2,152	1,363	1,687	758	585	1,131	1,028	453	474	791	730	80
Payments to Acquire Marketable Debt Securities
735	2,319	1,205	195	242	1,243	615	162	285	985	1,393	1,837	1,204	841	1,053	672	523	860	811	651	821	908	1,803	1,928	1,080	411	598	572	278	106	75	811	2,615	1,475	1,157	1,953	2,234	2,120	116	707	2,880	1,171	405	1,043	870
Payments to Acquire Property, Plant, and Equipment
186	251	190	191	204	290	224	198	239	254	262	248	291	371	341	261	242	285	234	165	136	191	107	110	118	200	124	98	115	175	137	113	123	134	84	74	75	125	89	81	129	196	169	164	201
Proceeds from Divestiture of Businesses, Net of Cash Divested
205	13,765	1,719	58	310	302	364	208	375	210	137	148	241	141	190	564	439	35	379	91	203	132	241	157	3,055	-	-	-	-	-	-	-	-	-	-	-	114	-	22	-2	37	-	-	-	65
Payments to Acquire Businesses, Net of Cash Acquired
25	24,576	9	34	15	31	45	834	336	54	353	207	112	48	44	259	8	-	-	-	-	6	0	192	21	-	-	-	-	0	5,039	0	2,491	-	-	-	-	-	-	-	-	-	-	-	-
Other investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-3	-	-1	-3	-12	-	-	-	-	-	-	-	-	-	-	-	-
Net Cash Provided by (Used in) Investing Activities
653	-12,036	491	715	1,060	-336	-147	-348	-43	1,019	142	-1,024	-203	16	-368	406	1,426	-984	-62	-1,280	754	351	164	-1,511	2,212	-315	-475	57	161	277	-4,203	226	-3,027	495	-163	-332	-1,437	-2,479	948	238	-2,519	-1,027	-1,989	-438	-926
Cash Flows From Financing Activities:
Proceeds from (Repayments of) Short-term Debt
26	16	31	157	-73	74	-71	-202	-344	-471	898	108	192	23	85	50	-33	-503	-113	427	-260	199	40	84	-79	-290	567	-630	551	29	-101	91	30	-68	-3	52	18	-87	-7	78	-17	-25	29	-32	2
Issuance of long-term debt
-	-	-	-	-	-	-	-	-	0	0	0	1,488	-	-	-	-	-	-	-	-	-	-	-	-	1,477	0	0	12	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Repayments of Long-term Debt
0	8,000	0	6	1,250	0	0	5	0	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	676	-	-	-	-	0	1,999	0	109	0	0	24	54	-	-	-	0	-	-	-	-
Interest rate swap contract terminations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-25	27	-101	0	0	-4	-	-	-	-	0	0	0	2	0	207	85	4	48	0	98	0	0	3	4	187
Issuance of common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	30	27	174	59	29	28	172	81	40	173	270	66	83	155	159	236	130	182	53	41	89	40	82	-	-	-	-
Payments for Repurchase of Common Stock
81	7,000	300	0	0	0	0	153	167	249	220	0	2,000	0	0	0	231	-	-	-	-	-	-	-	-	0	53	83	297	492	1,051	521	339	362	474	237	148	223	188	165	0	-	-	-	-
Payments of Dividends
1,017	668	671	671	669	653	653	654	653	639	640	643	655	635	636	635	641	618	617	619	623	598	597	598	605	577	577	575	580	561	571	575	579	560	564	565	565	549	550	552	551	626	626	615	616
Proceeds from (Payments for) Other Financing Activities
18	-13	-1	-2	-37	1	4	-1	-58	7	6	3	-38	22	5	33	-45	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from Mead Johnson initial public offering
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	782
Net Cash Provided by (Used in) Financing Activities
-1,054	-7,677	-941	18,268	-2,029	-578	-720	-1,015	-1,222	-1,352	-706	-1,006	-1,013	-605	-546	-552	-950	-1,359	-700	-883	-682	-231	-528	-486	-1,192	711	-620	-1,115	-44	-958	-1,689	-850	-836	-754	-704	-507	-692	-1,664	-698	-495	-486	994	-656	-710	355
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
-67	6	-21	3	3	-12	-3	-37	11	-7	25	6	28	-49	8	-3	11	-131	14	-3	25	-	-	-	2	9	-8	14	10	-2	10	-16	7	-4	-25	6	20	0	30	-9	-7	5	32	27	-25
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
3,426	-17,669	2,085	21,069	424	1,503	409	-343	-79	777	1,174	-440	-327	805	498	290	259	-1,590	-224	-2,095	723	720	569	-943	1,639	1,815	-50	466	-301	153	-1,298	494	-3,469	1,305	806	260	-1,628	-2,548	1,663	783	-2,548	1,316	-1,140	-325	-144